Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study

Por Gemelli, Maria, Elli, Elena Maria, Elena, Chiara, Iurlo, Alessandra, Intermesoli, Tamara, Maffioli, Margherita, Pungolino, Ester, Carraro, Maria Cristina, D’Adda, Mariella, Lunghi, Francesca, Anghileri, Michela, Polverelli, Nicola, Rossi, Marianna, Bacciocchi, Mattia, Bono, Elisa, Bucelli, Cristina, Passamonti, Francesco, Antolini, Laura, Gambacorti-Passerini, Carlo
Publicado no Blood Res (2020)

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of...

Por Trojani, Alessandra, Pungolino, Ester, Dal Molin, Alessandra, Lodola, Milena, Rossi, Giuseppe, D’Adda, Mariella, Perego, Alessandra, Elena, Chiara, Turrini, Mauro, Borin, Lorenza, Bucelli, Cristina, Malato, Simona, Carraro, Maria Cristina, Spina, Francesco, Latargia, Maria Luisa, Artale, Salvatore, Spedini, Pierangelo, Anghilieri, Michela, Di Camillo, Barbara, Baruzzo, Giacomo, De Canal, Gabriella, Iurlo, Alessandra, Morra, Enrica, Cairoli, Roberto
Publicado no PLoS One (2019)

Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients

Por Maffioli, Margherita, Giorgino, Toni, Mora, Barbara, Iurlo, Alessandra, Elli, Elena, Finazzi, Maria Chiara, Caramella, Marianna, Rumi, Elisa, Carraro, Maria Cristina, Polverelli, Nicola, D’Adda, Mariella, Malato, Simona, Rossi, Marianna, Molteni, Alfredo, Vismara, Alessandro, Sissa, Cinzia, Spina, Francesco, Anghilieri, Michela, Cattaneo, Daniele, Renso, Rossella, Bellini, Marta, Pioltelli, Maria Luisa, Cavalloni, Chiara, Barraco, Daniela, Accetta, Raffaella, Bertù, Lorenza, Della Porta, Matteo Giovanni, Passamonti, Francesco
Publicado no Blood Adv (2019)